Neogen (NEOG) Other Non-Current Assets (2011 - 2026)
Neogen's (NEOG) quarterly Other Non-Current Assets came in at $68.2 million in Q1 2026, up 139.05% year-on-year from $28.5 million in Q1 2025, and down 11.15% quarter-over-quarter from $76.8 million in Q4 2025.
Neogen (NEOG) Other Non-Current Assets (2011 - 2026) Analysis & Trends
Neogen's Other Non-Current Assets history runs 16 years deep, the most recent figure standing at $68.2 million for Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 139.05% year-over-year to $68.2 million in Q1 2026; TTM through Feb 2026 was $68.2 million, a 139.05% increase from a year earlier, with the FY2025 full-year figure at $35.2 million, up 72.33% from the prior year.
- Other Non-Current Assets eased to $68.2 million in Q1 2026 per NEOG's latest filing, from $76.8 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $3.8 billion in Q2 2023 and bottomed at $2.0 million in Q1 2022.
- The 5-year median for Other Non-Current Assets is $20.0 million (2024), against an average of $389.4 million.
- Across the five-year window, Other Non-Current Assets soared 174749.35% in 2023 and slumped 99.46% in 2024, its largest moves.
- Year by year, Other Non-Current Assets stood at $3.9 million in 2022, then soared by 309.73% to $16.0 million in 2023, then climbed by 26.42% to $20.2 million in 2024, then soared by 279.45% to $76.8 million in 2025, then dropped by 11.15% to $68.2 million in 2026.
- Per Business Quant, the three latest NEOG Other Non-Current Assets figures stand at $68.2 million (Q1 2026), $76.8 million (Q4 2025), and $2.5 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn | 68.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 68.20 Mn |
| Nov 30, 2025 | 76.76 Mn |
| Aug 31, 2025 | 2.51 Bn |
| May 31, 2025 | 35.20 Mn |
| Feb 28, 2025 | 28.53 Mn |
| Nov 30, 2024 | 20.23 Mn |
| Aug 31, 2024 | 20.00 Mn |
| May 31, 2024 | 20.43 Mn |
| Feb 29, 2024 | 16.36 Mn |
| Nov 30, 2023 | 16.00 Mn |
| Aug 31, 2023 | 16.05 Mn |
| May 31, 2023 | 3.77 Bn |
| Feb 28, 2023 | 13.84 Mn |
| Nov 30, 2022 | 3.91 Mn |
| Aug 31, 2022 | 2.16 Mn |
| May 31, 2022 | 2.16 Mn |
| Feb 28, 2022 | 2.02 Mn |
| Nov 30, 2021 | 2.02 Mn |
| Aug 31, 2021 | 2.02 Mn |
| May 31, 2021 | 228.29 Mn |